DOSSIET

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

Written by

Pam Belluck

in

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.

Pam Belluck
Author: Pam Belluck

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts